Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Dec;50(12):959–962. doi: 10.1136/ard.50.12.959

Management of the antiphospholipid syndrome.

M A Khamashta 1, T Wallington 1
PMCID: PMC1004593  PMID: 1768171

Full text

PDF
959

Images in this article

959Image
on p.959
960Image
on p.960

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Chan J. K., Harris E. N., Gharavi A. E., Hughes G. R. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985 Dec;44(12):823–825. doi: 10.1136/ard.44.12.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asherson R. A., Khamashta M. A., Gil A., Vazquez J. J., Chan O., Baguley E., Hughes G. R. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989 Apr;86(4):391–399. doi: 10.1016/0002-9343(89)90335-5. [DOI] [PubMed] [Google Scholar]
  3. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  4. BOWIE E. J., THOMPSON J. H., Jr, PASCUZZI C. A., OWEN C. A., Jr THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. J Lab Clin Med. 1963 Sep;62:416–430. [PubMed] [Google Scholar]
  5. Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 Nov 21;313(21):1322–1326. doi: 10.1056/NEJM198511213132104. [DOI] [PubMed] [Google Scholar]
  6. Galli M., Comfurius P., Maassen C., Hemker H. C., de Baets M. H., van Breda-Vriesman P. J., Barbui T., Zwaal R. F., Bevers E. M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990 Jun 30;335(8705):1544–1547. doi: 10.1016/0140-6736(90)91374-j. [DOI] [PubMed] [Google Scholar]
  7. Gonzalez-Buritica H., Khamashta M. A., Hughes G. R. Is there a role for phospholipases in the anti-cardiolipin syndrome? Clin Exp Rheumatol. 1988 Oct-Dec;6(4):341–342. [PubMed] [Google Scholar]
  8. Harris E. N., Chan J. K., Asherson R. A., Aber V. R., Gharavi A. E., Hughes G. R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med. 1986 Nov;146(11):2153–2156. [PubMed] [Google Scholar]
  9. Johnson R., Charnley J. Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty. Clin Orthop Relat Res. 1979 Oct;(144):174–177. [PubMed] [Google Scholar]
  10. Khamashta M. A., Cervera R., Asherson R. A., Font J., Gil A., Coltart D. J., Vázquez J. J., Paré C., Ingelmo M., Oliver J. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990 Jun 30;335(8705):1541–1544. doi: 10.1016/0140-6736(90)91373-i. [DOI] [PubMed] [Google Scholar]
  11. Lockshin M. D., Druzin M. L., Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 1989 Feb;160(2):439–443. doi: 10.1016/0002-9378(89)90468-7. [DOI] [PubMed] [Google Scholar]
  12. Lockshin M. D., Qamar T., Druzin M. L., Goei S. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol. 1987 Apr;14(2):259–262. [PubMed] [Google Scholar]
  13. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  14. McHugh N. J., Reilly P. A., McHugh L. A. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol. 1989 Jan;16(1):42–46. [PubMed] [Google Scholar]
  15. McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990 Jun;87(11):4120–4124. doi: 10.1073/pnas.87.11.4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morgan-Capner P., Hodgson J., Hambling M. H., Dulake C., Coleman T. J., Boswell P. A., Watkins R. P., Booth J., Stern H., Best J. M. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet. 1985 Feb 2;1(8423):244–246. doi: 10.1016/s0140-6736(85)91027-x. [DOI] [PubMed] [Google Scholar]
  17. SNEDDON I. B. CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS. Br J Dermatol. 1965 Apr;77:180–185. doi: 10.1111/j.1365-2133.1965.tb14628.x. [DOI] [PubMed] [Google Scholar]
  18. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  19. Triplett D. A., Harris E. N. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol. 1989 Nov-Dec;21(3-4):123–131. doi: 10.1111/j.1600-0897.1989.tb01016.x. [DOI] [PubMed] [Google Scholar]
  20. Trudinger B. J., Stewart G. J., Cook C. M., Connelly A., Exner T. Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol. 1988 Aug;72(2):215–218. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES